When A Single Shot Is A Problem: J&J’s Study Of Two Doses Raises Equality, Distribution Questions
FDA and CDC advisory committee members wonder how to use the single-shot J&J vaccine if an ongoing study shows two doses are better than one.
You may also be interested in...
US FDA will determine on a case-by-case basis whether its inability to inspect a facility because of the pandemic could result in 180-day exclusivity forfeiture for first generic filers.
The arrival of another vaccine is welcome news for Europe’s stuttering COVID-19 vaccination program, but it will be weeks before J&J’s production is up to speed.
J&J CEO Gorsky says the agency is working with sponsors to ensure the proper data is gathered to make the vaccine available in children.